Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study.
Therap Adv Gastroenterol
; 12: 1756284819878660, 2019.
Article
in En
| MEDLINE
| ID: mdl-31598136
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Therap Adv Gastroenterol
Year:
2019
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom